Deciphering the therapeutic potential of bergenin in breast cancer: In silico insights into HSP90AA1 and HRAS interaction mediated inhibition of PI3K-Akt and MAPK signaling pathway. IJBB. 2024;61(11):639-658. doi:10.56042/ijbb.v61i11.6391